According to the Legislative Budget Board (LBB), SB 1185 would result in an estimated negative impact of $196,140 to the General Revenue Fund over the 2026–2027 biennium. The bill, by exempting certain small boilers used in medical devices and autoclaves from registration and inspection requirements, would reduce the number of boilers subject to regulation by the Texas Department of Licensing and Regulation (TDLR).
TDLR currently collects a $70 annual fee for each boiler's certificate of operation. With the proposed exemption affecting approximately 1,245 boilers, this would result in an annual revenue loss of $87,150. Additionally, TDLR conducts around 156 inspections per year for these boilers, each also generating a $70 fee, totaling $10,920 in lost inspection revenue annually. Combined, the state would see a total annual revenue loss of $98,070.
While the bill does not appropriate funds, it could provide a legal basis for future appropriations to cover any resulting shortfalls. Importantly, the fiscal impact is limited to state revenue, with no anticipated fiscal implications for local governments.
SB 1185 presents a targeted and pragmatic reform aimed at aligning state boiler regulations with existing federal oversight for certain FDA-regulated medical equipment. As clarified in the bill analysis, the intent behind SB 1185 is to eliminate duplicative state-level registration and inspection requirements for small boilers integrated into medical devices and autoclaves, which are already under stringent federal supervision. This effort reflects a broader legislative trend toward streamlining compliance obligations, especially in sectors like healthcare, where regulatory redundancy can stifle innovation and efficiency.
From a liberty principle perspective, the bill supports Individual Liberty and Free Enterprise by reducing governmental interference in the use of medical technology. It acknowledges the sufficiency of federal safety protocols while removing an unnecessary layer of state bureaucracy. In doing so, the bill also upholds Limited Government, minimizing state involvement where it adds no substantial public benefit.
Though the bill carries a modest fiscal cost—an estimated $98,070 annual loss to the General Revenue Fund due to reduced fees—the economic relief it offers to healthcare providers and manufacturers could have a broader positive impact on medical service delivery and equipment accessibility. These benefits outweigh the minor revenue impact, especially considering the state's responsibility to avoid overregulation and promote operational efficiency in vital sectors like healthcare.
Overall, SB 1185 is a well-reasoned initiative that balances public safety, economic efficiency, and regulatory reform, and it aligns with the core liberty principles. As such, Texas Policy Research recommends that lawmakers vote YES on SB 1185.